GL1X · GenesisL1 explorer

MolNFT v1 · #135631 · protein

Crystal structure of the broadly neutralizing influenza a antibody vrc 315 53-1A09 Fab.

5U4R · Vrc 315 53-1A09 Fab heavy chain: “Crystal structure of the broadly neutralizing influenza a antibody vrc 315 53-1A09 Fab.”. X-ray diffraction, 8 pockets (best druggability 0.77). MolNFT v1 #135631 on GenesisL1: 3D structure, binding…

PDB
5U4R
Type
protein
Length
891 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vrc 315 53-1A09 Fab heavy chain; Vrc 315 53-1A09 Fab light chain
Pockets
8 · best druggability 0.77

Structure

x-ray diffraction · 4 distinct chains · 7% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVrc 315 53-1A09 Fab heavy chainprotein2329% helix, 48% strand—
BVrc 315 53-1A09 Fab light chainprotein2126% helix, 50% strand—
HVrc 315 53-1A09 Fab heavy chainprotein2339% helix, 47% strand—
LVrc 315 53-1A09 Fab light chainprotein2145% helix, 50% strand—

Pockets

8 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19910.770.7991empty
25230.660.7749empty
33530.640.7943empty
42390.530.7644empty
52260.510.7635empty

Interfaces

5 interfaces between chains.

  • H–L · 2029 Ų buried · 18 hydrogen bonds · protein-protein
  • A–B · 1958 Ų buried · 18 hydrogen bonds · protein-protein
  • B–L · 371 Ų buried · 3 hydrogen bonds · protein-protein
  • B–H · 126 Ų buried · 0 hydrogen bonds · protein-protein
  • A–L · 90 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 9 disulfide (disulfide).

Compared structures

  • 5U4R · Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 53-1A09 Fab. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.